Linvoseltamab versus elranatamab for triple-class exposed relapsed or refractory multiple myeloma: an indirect treatment comparison.
Saved in:
| Title: | Linvoseltamab versus elranatamab for triple-class exposed relapsed or refractory multiple myeloma: an indirect treatment comparison. |
|---|---|
| Authors: | Richter, Joshua1 (AUTHOR) joshua.richter@mountsinai.org, Lee, Hans C.2 (AUTHOR), Jagannath, Sundar1 (AUTHOR), Zonder, Jeffrey A.3 (AUTHOR), Hoffman, James E.4 (AUTHOR), Zhou, Zheng-Yi5 (AUTHOR), Garcia-Horton, Viviana5 (AUTHOR), Fillbrunn, Mirko5 (AUTHOR), Wang, Hongjue5 (AUTHOR), Mattera, Matthew5 (AUTHOR), Inocencio, Timothy J.6 (AUTHOR), Xu, Yingxin6 (AUTHOR), Harnett, James6 (AUTHOR), Roccia, Tito6 (AUTHOR), Kroog, Glenn S.6 (AUTHOR), Rodriguez Lorenc, Karen6 (AUTHOR), Knorr, Kate6 (AUTHOR), Ma, Qiufei6 (AUTHOR), Bumma, Naresh7 (AUTHOR) |
| Source: | Leukemia & Lymphoma. Jul2026, p1-13. 13p. 3 Illustrations. |
| Database: | Academic Search Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 195212493 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Linvoseltamab versus elranatamab for triple-class exposed relapsed or refractory multiple myeloma: an indirect treatment comparison. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Richter%2C+Joshua%22">Richter, Joshua</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> joshua.richter@mountsinai.org</i><br /><searchLink fieldCode="AR" term="%22Lee%2C+Hans+C%2E%22">Lee, Hans C.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jagannath%2C+Sundar%22">Jagannath, Sundar</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zonder%2C+Jeffrey+A%2E%22">Zonder, Jeffrey A.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hoffman%2C+James+E%2E%22">Hoffman, James E.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhou%2C+Zheng-Yi%22">Zhou, Zheng-Yi</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Garcia-Horton%2C+Viviana%22">Garcia-Horton, Viviana</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fillbrunn%2C+Mirko%22">Fillbrunn, Mirko</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Hongjue%22">Wang, Hongjue</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mattera%2C+Matthew%22">Mattera, Matthew</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Inocencio%2C+Timothy+J%2E%22">Inocencio, Timothy J.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xu%2C+Yingxin%22">Xu, Yingxin</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Harnett%2C+James%22">Harnett, James</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Roccia%2C+Tito%22">Roccia, Tito</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kroog%2C+Glenn+S%2E%22">Kroog, Glenn S.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rodriguez+Lorenc%2C+Karen%22">Rodriguez Lorenc, Karen</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Knorr%2C+Kate%22">Knorr, Kate</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ma%2C+Qiufei%22">Ma, Qiufei</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bumma%2C+Naresh%22">Bumma, Naresh</searchLink><relatesTo>7</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Leukemia+%26+Lymphoma%22">Leukemia & Lymphoma</searchLink>. Jul2026, p1-13. 13p. 3 Illustrations. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=195212493 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/10428194.2026.2688561 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 13 StartPage: 1 Titles: – TitleFull: Linvoseltamab versus elranatamab for triple-class exposed relapsed or refractory multiple myeloma: an indirect treatment comparison. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Richter, Joshua – PersonEntity: Name: NameFull: Lee, Hans C. – PersonEntity: Name: NameFull: Jagannath, Sundar – PersonEntity: Name: NameFull: Zonder, Jeffrey A. – PersonEntity: Name: NameFull: Hoffman, James E. – PersonEntity: Name: NameFull: Zhou, Zheng-Yi – PersonEntity: Name: NameFull: Garcia-Horton, Viviana – PersonEntity: Name: NameFull: Fillbrunn, Mirko – PersonEntity: Name: NameFull: Wang, Hongjue – PersonEntity: Name: NameFull: Mattera, Matthew – PersonEntity: Name: NameFull: Inocencio, Timothy J. – PersonEntity: Name: NameFull: Xu, Yingxin – PersonEntity: Name: NameFull: Harnett, James – PersonEntity: Name: NameFull: Roccia, Tito – PersonEntity: Name: NameFull: Kroog, Glenn S. – PersonEntity: Name: NameFull: Rodriguez Lorenc, Karen – PersonEntity: Name: NameFull: Knorr, Kate – PersonEntity: Name: NameFull: Ma, Qiufei – PersonEntity: Name: NameFull: Bumma, Naresh IsPartOfRelationships: – BibEntity: Dates: – D: 10 M: 07 Text: Jul2026 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 10428194 Titles: – TitleFull: Leukemia & Lymphoma Type: main |
| ResultId | 1 |